Fulgent Genetics - About the company
Fulgent Genetics is an acquired company based in Temple City (United States), founded in 2011. It operates as a Provider of genetic testing services for carrier screening cardiovascular diseases, epilepsy and cancer. Fulgent Genetics has raised $34.8M in funding, with last known valuation of $*****. The company has 73 active competitors, including 18 funded and 12 that have exited. Its top competitors include companies like Myriad Genetics, Invitae and Celmatix.
Company Details
Provider of genetic testing services for carrier screening cardiovascular diseases, epilepsy, and cancer. BY using next-generation sequencing technology it offers services for rare diseases, whole-genome sequencing, whole-genome copy number variation analysis, and mitochondrial sequencing.
- Website
- fulgentgenetics.com
- Social
- Email ID
- *****@fulgentgenetics.com
- Phone Number
- +1 **********
- Registered Address
- Temple City, California
Key Metrics
Founded Year
2011
Location
Temple City, United States
Stage
Acquired
Total Funding
$34.8M in 3 rounds
Latest Funding Round
Last Known Valuation
$***** as on Nov 07, 2022
Ranked
1st among 73 active competitors
Employee Count
446 as on Sep 30, 2026
Similar Companies
Exit Details
Acquired by Fulgent Pharma (Nov 07, 2022)
Legal entities associated with Fulgent Genetics
Fulgent Genetics is associated with 3 legal entities given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Reports |
|---|---|---|---|---|
FULGENT GENETICS, INC. CIN: 32063924230 , United States, Active | - | - | - | |
FULGENT GENETICS, INC. CIN: 6000989 , United States, Active | May 12, 2016 | - | 645 (As on Feb 28, 2022) | - |
FULGENT THERAPEUTICS LLC CIN: 320400050 , United States, Active | Dec 31, 1999 | - | 1139 (As on Dec 31, 2024) | - |
Fulgent Genetics's acquisition details
Fulgent Genetics got acquired by Fulgent Pharma on Nov 07, 2022 at an acquisition amount of $*****.
Click here to take a look at Fulgent Genetics's acquisition in detail
Sign up to download Fulgent Genetics' company profile
Fulgent Genetics's funding and investors
Fulgent Genetics has raised a total funding of $34.8M over 3 rounds. Its first funding round was on Oct 16, 2015.
Here is the list of recent funding rounds of Fulgent Genetics:
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
May 17, 2016 | 6099856 | Series A | 6810578 | 9149996 | 9360739 | 4289666 |
Apr 04, 2016 | 3419916 | Series A | 4599831 | 5962894 | 5081182 | 5858677 |
Oct 16, 2015 | 1613225 | Seed | 1014162 | 1185443 | 1589054 | 9719792 |
Access funding benchmarks and valuations. Sign up today!View details of Fulgent Genetics's funding rounds and investors
Fulgent Genetics' founders and board of directors
Founder? Claim ProfileFulgent Genetics' employee count trend
Fulgent Genetics has 446 employees as of Sep 26. Here is Fulgent Genetics's employee count trend over the years:
Uncover Fulgent Genetics' growth story! Sign up today!
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Fulgent Genetics's Competitors and alternates
Top competitors of Fulgent Genetics include Myriad Genetics, Invitae and Celmatix. Here is the list of Top 10 competitors of Fulgent Genetics, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Fulgent Genetics 2011, Temple City (United States), Acquired | Provider of genetic testing services for carrier screening cardiovascular diseases, epilepsy and cancer | $34.8M | - | 70/100 |
2nd | Myriad Genetics 1991, United States, Public | Developer of molecular diagnostics and personalized medicine for cancer | - | 68/100 | |
3rd | Invitae 2010, San Francisco (United States), Public | Provider of home-based genetic test for individuals | $190M | 68/100 | |
4th | Celmatix 2009, New York City (United States), Series C | Pioneering ovarian health therapeutics for women's unique biological needs | $24.9M | 59/100 | |
5th | Genome Medical 2016, Monterey (United States), Series D | Provider of clinical and DTC genomic testing services | $173M | 57/100 | |
6th | Blueprint Genetics 2012, Espoo (Finland), Acquired | Provider of genetic diagnostics and clinical interpretation for hereditary diseases | $26.2M | 51/100 | |
7th |  Aspira Women's Health 1993, Austin (United States), Public | Provider of diagnostic solution for ovarian malignancy in women | - | - | 50/100 |
8th | Developer of high throughput gene sequencing platform for clinical application | $73M | 48/100 | ||
9th | Recombine 2011, New York City (United States), Acquired | Genetic testing services | $12.1M | 48/100 | |
10th | Provider of internet first diagnostics platform for genetic tests | $60M | 47/100 |
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!Looking for more details on Fulgent Genetics's competitors? Click here to see the top ones
Fulgent Genetics's Investments and acquisitions
Fulgent Genetics has made 1 investments in companies including Spatial Genomics. Fulgent Genetics has also acquired 8 companies including StrataDx and BakoDx.Here is the list of investments & acquisitions:
Filter this list
Filter this listDate of Investment/Acquisition | Type | Company Name | Founded Year | Location |
|---|---|---|---|---|
Dec 22, 2025 | Acquisition | 2006 | Lexington (United States) | |
Dec 22, 2025 | Acquisition | 2007 | Alpharetta (United States) | |
Nov 07, 2022 | Acquisition | 2011 | Temple City (United States) |
_1578992469545.png?devicePixelRatio=2&height=20&width=20){kind=logo}
Want to know more about where corporates are investing? Sign up today!See all acquisitions by Fulgent Genetics
Reports related to Fulgent Genetics
Here is the latest report on Fulgent Genetics's geography:
News related to Fulgent Genetics
Filter this listMedia has covered Fulgent Genetics for a total of 16 events in the last 1 year, 4 of them have been about company updates.
•
Lowey Dannenberg Investigates Fulgent Genetics Inc. (NASDAQ: FLGT) for Potential Securities Law ViolationsBenzinga•May 22, 2026•Lowey, Fulgent Genetics
•
Fulgent Announces Rapid Oral Full Abstract Publication for FID-007 Within the Head and Neck Cancer Track Session at the ASCO 2026 Annual MeetingBusiness Wire•May 21, 2026•Fulgent Genetics
•
•
Lowey Dannenberg, P.C. is Investigating Fulgent Genetics Inc. (NASDAQ: FLGT) for Potential Violations of the Federal Securities Laws and Encourages Investors to Contact the FirmFinancial Post•Apr 18, 2026•Lowey, Fulgent Genetics
•
Fulgent Genetics Completes Acquisition of Bako Diagnostics and StrataDxBusiness Wire•Mar 17, 2026•BakoDx, StrataDx, Fulgent Genetics
•
Lowey Dannenberg, P.C. is Investigating Fulgent Genetics Inc. (NASDAQ: FLGT)GlobeNewswire•Mar 12, 2026•Lowey, Fulgent Genetics, BakoDx, StrataDx
•
Fulgent Genetics Non-GAAP EPS of $0.16 beats by $0.13, revenue of $83.3M misses by $2.08MSeeking Alpha•Feb 27, 2026•Fulgent Genetics
•
Fulgent Reports Fourth Quarter and Full Year 2025 Financial ResultsBusiness Wire•Feb 27, 2026•Fulgent Genetics
•
Fulgent to Acquire Two Laboratories for $56 MillionLos Angeles Business Journal•Jan 12, 2026•BakoDx, StrataDx, Fulgent Genetics
•
Fulgent Genetics Agrees to Acquire Bako Diagnostics and StrataDxYahoo•Dec 23, 2025•Fulgent Genetics, StrataDx, BakoDx
Get curated news about company updates, funding rounds, M&A deals and others. Sign up today!Are you a Founder ?
FAQs about Fulgent Genetics
Explore our recently published companies
- Brandlite Consulting - Lagos based, 2025 founded, Unfunded company
- Jbharath Ayurvedics - Kollam based, 1940 founded, Unfunded company
- J&R Precision Drilling - Miami based, 2010 founded, Unfunded company
- Proin Procedimientos Integrados - Sevilla La Nueva based, 1994 founded, Unfunded company
- St. Louis Designs - Unfunded company
- Grupo Alvamex - La Barca based, 1985 founded, Public company
